PEAR THERAPEUTICS PARTNERS WITH WESTWOOD & WILSHIRE TO FILL VICE PRESIDENT OF DISCOVERY AND TRANSITIONAL RESEARCH

Dr. Mark Deeg has joined Pear Therapeutics as the new Vice President of Discovery and Transitonal Research.  Dr. Deeg has joined from Regulus Therapeutics where he served as Chief Medical Officer for the past year. Prior to Regulus, he has served as Chief Medical Officier at Eli Lilly and Company where he was has held positions of increasing responsiblity. Dr. Deeg recieved a degree in Medicine (M.D.) and a PhD in Pharmacology at the University of Minnesota.

This search was successfully led by Michael Cane.

At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Our firm has offices in Los Angeles, Silicon Valley, and Seattle, serving clients on a local, national and global basis.